Aytu BioPharma divests Consumer Health business to private e-commerce firm; receives royalty payments

AYTU BIOPHARMA, INC

Divested Consumer Health (Innovus Pharmaceuticals) to an undisclosed private e-commerce company after winding down operations.
Aytu receives revenue-based royalty payments on future sales of former Consumer Health products.
Company now focuses solely on its prescription pharmaceutical segment to drive profitability.
Wind down eliminated materially all remaining Consumer Health expenses; near adjusted EBITDA breakeven during wind-down.
Closure of Grand Prairie, TX manufacturing site expected to further enhance operating margins.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.